NasdaqHealth CarePharmaceutical PreparationsWEST CHESTER, PA

Verrica Pharmaceuticals Inc. VRCA

Ask your AI

Estimated market cap $61.16M17.18M shares, shares as of Nov 5, 2026CIK 1660334

Insider trades, 12 mo

12 buys · 0 sells

$18.17M bought, open market

Congress trades, 24 mo

—

No disclosed trades

13F holders, Q3 2026

9.6% of shares · 5 added

13F holders

…

Lobbying, 12 mo

—

No lobbying filings

Federal contracts, 12 mo

—

None matched

Ask your AI:

Latest 10-Q

Q3 2026

What changed in Verrica Pharmaceuticals Inc.'s latest quarterly report, compared with the one before.

Filed Nov 13, 2026 · Quarter ended Sep 30, 2026

Compared with the 10-Q for the quarter ended Jun 30, 2026. Sections compared: management's discussion, risk factors, legal proceedings and controls and procedures.

Read the 10-Q on sec.gov ↗Filing index ↗

Latest 10-Q

What changed in Verrica Pharmaceuticals Inc.'s latest quarterly report, compared with the one before.

Loading…

Insider trades

12 in 12 mo

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

No open-market insider trades reported since Aug 18, 2026. Insiders have two business days to file.

Recent insider trades

Noah L. Rosenberg CMO	Aug 18 Form 4 ↗	Buy	+$9,988 2,030 sh @ $4.92	-22.2%
John J. Kirby Interim CFO	Aug 18 Form 4 ↗	Buy	+$24.6K 5,000 sh @ $4.93	-22.2%
Jayson Rieger CEO and President, Director	Aug 17 Form 4 ↗	Buy	+$24.6K 5,000 sh @ $4.91	-24.8%
David Zawitz Chief Operating Officer	Aug 17 Form 4 ↗	Buy	+$29.9K 6,000 sh @ $4.98	-24.8%
Noah L. Rosenberg CMO	Aug 17 Form 4 ↗	Buy	+$20.6K 4,200 sh @ $4.91	-24.8%

All VRCA insider trades →Planned sales (Form 144): see notices

Insider trades

Open-market trades from Form 4. 10b5-1 marks a plan set in advance.

Loading…

13F holders

1.64M shares

25 funds report VRCA. Values checked against market prices.

Funds own 27% of shares (Q2 2026)

43 funds hold the stock.

Q3 2026: 9.6% · 5,560 of ~8,900 funds reported so far

Q2 20250.2%
Q3 202526%
Q4 202555%
Q1 202628%
Q2 202627%
Q3 2026 (so far)9.6%

Q3 2026. 2 new, 5 added to, 9 trimmed, 19 exited since Q2 2026.

Top 13F holders
#
1	Affinity Asset Advisors, LLC 13F ↗	688,654	$3.3M	-2.6%
2	Vanguard Capital Management LLC 13F ↗	351,910	$1.7M	+26.0%
3	Mariner, LLC 13F ↗	214,030	$1.0M	+3.3%
4	Geode Capital Management, LLC 13F ↗	128,298	$615.3K	-7.1%
5	BlackRock, Inc. 13F ↗	72,098	$345.7K	-3.0%
6	Vanguard Fiduciary Trust Co 13F ↗	53,505	$256.6K	-23.8%
7	Renaissance Technologies LLC 13F ↗	31,884	$152.9K	+46.5%
8	State Street Corp 13F ↗	28,916	$138.7K	unchanged
9	Fifth Third Bancorp 13F ↗	28,000	$134.3K	+100.0%
10	Jane Street Group, LLC 13F ↗	16,297	$78.1K	-31.1%

Download CSV Every fund that holds VRCA, not only these ten. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

13F holders

Funds that report this stock, checked against market prices.

Loading…

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

No recent congressional trades for this company.

Trades by members of Congress

Disclosed in dollar ranges, up to 45 days after the trade.

Loading…

Lobbying

What Verrica Pharmaceuticals Inc. and its lobbying firms report each quarter.

No recent lobbying filings for this company.

Lobbying

What Verrica Pharmaceuticals Inc. and its lobbying firms report each quarter.

Loading…

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Funds holding the stock

Shares they report, adjusted for splits

Funds holding the stock by quarter

Q2 2025	5	—	19,402	$102.8K
Q3 2025	33	+28	2.47M	$10.6M
Q4 2025	50	+17	5.20M	$43.2M
Q1 2026	39	-11	4.78M	$25.3M
Q2 2026	43	+4	4.66M	$28.5M
Q3 2026	25	-18	1.64M	$7.8M

Each point is a quarter-end, from Q2 2025 to Q3 2026. A fund's 13F lists its long positions in US-listed securities as of the last day of the quarter and arrives up to 45 days later, so each point shows holdings at quarter-end, not on the day they were reported.

Common shares only; options and bonds are left out. When a fund amends a report, the amended version is the one counted.

The history follows the company's current CUSIP number (92511W207). If the company's shares were ever re-issued under a different CUSIP, the quarters before the change are not part of this series, so the first point (Q2 2025) can be later than the stock's first appearance in 13F reports.

Share counts are adjusted for stock splits (1-for-10 on Jul 25, 2025): reports from before a split are multiplied by its ratio, so every quarter is on the share count of Q3 2026.

A quarter appears once our daily update has built its summary. If a summary cannot be built, older reports are kept and the chart shows the quarters it has until the next update repairs it.

Institutional ownership over time

How many funds reported holding the stock at the end of each quarter, and how many shares they held between them.

Loading…

More filings and data

Each opens the table.

Ownership stakes7 in 12 mo 8-K events1 in 90 days Patents3 patents granted Short interestFINRA · updated Oct 15 Planned insider salesNone in 12 mo Executive pay3 fiscal years Wikipedia attentionNone on record SEC enforcementNone on record Clinical trials4 active IPO history1 registration Ownership stakes…8-K events…Patents…Short interest…Planned insider sales…Executive pay…Wikipedia attention…SEC enforcement…

About the company

The basics from the company’s SEC registration.

Legal name: Verrica Pharmaceuticals Inc.
Address: 44 WEST GAY STREET, SUITE 400, WEST CHESTER, PA
Phone: 484-453-3300
Fiscal year ends: Dec 31
Filer category: Non-accelerated filer, smaller reporting company
Incorporated in: DE
Listed as: VRCA (Nasdaq)
SEC filings: All filings on SEC EDGAR ↗

About the company

The basics from the company’s SEC registration.

Loading…

$3.56−$0.16 (−4.30%) Nov 13 close

1M3M1Y

Oct 13, 2026Low $3.09 · High $3.91Nov 13, 2026

Aug 13, 2026Low $3.09 · High $5.69Nov 13, 2026

Nov 13, 2025Low $3.09 · High $9.10Nov 13, 2026

Congress purchase Congress sale Insider sale over $1M

Adjusted for stock splits; not for dividends. Where prices come from.

Live chart

Intraday and historical prices from TradingView. Quotes may be delayed.

Loading chart…

Information, not investment advice. Company matching is automatic; check the source before relying on one row.